Harding Loevner’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,234
Closed -$40K 108
2022
Q3
$40K Hold
3,234
﹤0.01% 103
2022
Q2
$63K Hold
3,234
﹤0.01% 96
2022
Q1
$71K Buy
3,234
+2,480
+329% +$66K ﹤0.01% 92
2021
Q4
$21K Hold
754
﹤0.01% 139
2021
Q3
$24K Hold
754
﹤0.01% 120
2021
Q2
$26K Buy
754
+585
+346% +$19.3K ﹤0.01% 122
2021
Q1
$5K Hold
169
﹤0.01% 152
2020
Q4
$5K Hold
169
﹤0.01% 143
2020
Q3
$5K Hold
169
﹤0.01% 175
2020
Q2
$4K Hold
169
﹤0.01% 141
2020
Q1
$4K Hold
169
﹤0.01% 144
2019
Q4
$5K Hold
169
﹤0.01% 137
2019
Q3
$4K Sell
169
-2,022
-92% -$60.7K ﹤0.01% 131
2019
Q2
$74K Buy
+2,191
New +$71.1K ﹤0.01% 94

Other funds holding ELAN

Harding Loevner's ELAN Position: Q4 2022 in Review

Harding Loevner sold out of Elanco Animal Health (ELAN) in Q4 2022, closing a stake of 3,234 shares — an estimated $40K sold.

Harding Loevner first reported a position in ELAN in Q2 2019 and held it in 14 quarters. The position peaked at $74K in Q2 2019. 404 funds tracked by Wall St. Rank hold ELAN as of Q4 2022.

  • Harding Loevner reported no remaining Elanco Animal Health position as of Q4 2022 after selling out during the quarter.
  • Harding Loevner sold 3,234 Elanco Animal Health shares in Q4 2022, an estimated $40K.
  • Harding Loevner first reported a position in Elanco Animal Health in Q2 2019 and held it in 14 quarters.
  • Harding Loevner's Elanco Animal Health position peaked at $74K in Q2 2019.
  • 404 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2022.

Based on Harding Loevner's 13F filing for Q4 2022, filed 14 Feb 2023.